Hiroki Ashizawa, Takahiro Takazono, Shin-Ya Kawashiri, Nana Nakada, Yuya Ito, Nobuyuki Ashizawa, Tatsuro Hirayama, Masataka Yoshida, Kazuaki Takeda, Naoki Iwanaga, Shinnosuke Takemoto, Shotaro Ide, Tomo Mihara, Shinya Tomari, Noriho Sakamoto, Yasushi Obase, Koichi Izumikawa, Katsunori Yanagihara, Atsushi Kawakami, Hiroshi Mukae
BACKGROUND: Evidence regarding the association of the usage of biologic agents (Etanercept, Tocilizumab, adalimumab and so on), such as anti-tumor necrosis factor α, with the incidence and risk factors of non-tuberculous Mycobacteria (NTM) infection is limited. Therefore, this study aimed to investigate the incidence and risk factors of NTM and their associations with biologic agents' usage, and also investigated the potential of Mycobacterium avium complex (MAC) antibodies as a predictor of NTM infection development...
February 23, 2024: Respiratory Investigation